Independent fund research. Built on SEC filings.

How we research funds

ETF · Leveraged & Inverse · Direxion

CURE Alternatives & Equivalents

Ticker CURE · · Holdings as of Jul 31, 2026

Expense ratio
0.94%$94/yr per $10k
5-yr return
+8.6%annualized
1-yr return
+22.9%as of Dec 2025
Net assets
$171.7Mall share classes
Holdings
67

Bottom line

What is similar to CURE?

We compared CURE's top holdings against every leveraged & inverse fund. The closest match is TBXU (Direxion Daily Biotech Top 5 Bull 2X ETF), with about 39% portfolio overlap.

Funds most similar to CURE

Ranked by top-holdings overlap
FundFamilyExpense ratio5-yr returnOverlap
TBXU Direxion Daily Biotech Top 5 Bull 2X ETFDirexion0.98%—39% Compare
PLTD Direxion Daily PLTR Bear 1X ETFDirexion0.98%—36% Compare
HIBS Direxion Daily S&P 500(R) High Beta…Direxion1.06%−55.6%35% Compare
ELIL Direxion Daily LLY Bull 2X ETFDirexion1.07%—37% Compare
TYO Direxion Daily 7-10 Year Treasury Bear…Direxion1%+13.2%36% Compare
METD Direxion Daily META Bear 1X ETFDirexion1.02%—35% Compare
QCMD Direxion Daily QCOM Bear 1X ETFDirexion1%—36% Compare
LABU Direxion Daily S&P Biotech Bull 3X ETFDirexion0.96%−39.6%34% Compare
AMZU Direxion Daily AMZN Bull 2X ETFDirexion0.99%—33% Compare
TSLS Direxion Daily TSLA Bear 1X ETFDirexion0.95%—34% Compare

Overlap = share of the two funds' top-25 holdings (by weight) that they have in common, from SEC Form N-PORT. Funds that hold other funds are matched by benchmark when holdings aren't comparable.